Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

p53 Mutants Suppress ZBP-89 Function

MORIHIRO OKADA, ARTHUR TESSIER, LONGCHUAN BAI and JUANITA L. MERCHANT
Anticancer Research May 2006, 26 (3A) 2023-2028;
MORIHIRO OKADA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ARTHUR TESSIER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LONGCHUAN BAI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JUANITA L. MERCHANT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: merchanj{at}umich.edu
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background: ZBP-89 is a widely expressed Krüppel-type zinc finger transcription factor that binds to GC-rich elements and represses or activates known target genes. ZBP-89 stabilizes wild-type p53 and can induce apoptosis independently of p53. Tissues with p53 mutations are predisposed to transformation and are more resistant to chemotherapy. Materials and Methods: The effect of ZBP-89 on seven sporadic p53 mutants was investigated. It was then examined whether a cell null for p53 in comparison to one expressing mutated p53 is more sensitive or resistant to chemotherapy in the presence of increased levels of ZBP-89. Results: None of the p53 mutations were stabilized by ZBP-89 except for the A161T p53 mutation, which exhibited constitutive transcriptional activity. ZBP-89 potentiated p53-mediated cell death with 10 nM staurosporine and 100 nM etoposide, but did not in the presence of the R273H p53 mutation. Conclusion: ZBP-89 is an important co-activator of wild-type p53 and both proteins are negatively affected by functionally inactive p53 mutants.

  • Cell cycle
  • apoptosis
  • colon cancer
  • etoposide
  • staurosporine

Footnotes

  • Abbreviations: Wild-type (WT), etoposide (ETO), staurosporine (STS).

  • Received January 24, 2006.
  • Accepted March 10, 2006.
  • Copyright© 2006 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 26, Issue 3A
May-June 2006
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
p53 Mutants Suppress ZBP-89 Function
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
p53 Mutants Suppress ZBP-89 Function
MORIHIRO OKADA, ARTHUR TESSIER, LONGCHUAN BAI, JUANITA L. MERCHANT
Anticancer Research May 2006, 26 (3A) 2023-2028;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
p53 Mutants Suppress ZBP-89 Function
MORIHIRO OKADA, ARTHUR TESSIER, LONGCHUAN BAI, JUANITA L. MERCHANT
Anticancer Research May 2006, 26 (3A) 2023-2028;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Mutational likeliness and entropy help to identify driver mutations and their functional role in cancer
  • Google Scholar

More in this TOC Section

  • Fosnetupitant Versus Fosaprepitant for Delayed Vomiting Upon Irinotecan–Oxaliplatin Combination Chemotherapy for Pancreatic/Colorectal Cancer
  • MMP-9 Genotypes Serve as Oral Cancer Predictive Marker for Smokers
  • A RANKL-derived Peptide Inhibits RSPO3-LGR4-Wnt Signaling and Lung Adenocarcinoma in Mice
Show more Experimental Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire